Contents

Recent Patents on Anti-Cancer Drug Discovery, Volume 9 - Number 3

Targeting Hormonal Signaling Pathways in Castration Resistant Prostate Cancer

, 9(3): 267 - 285

Marilena Manea, Marina Montagnani Marelli, Roberta M. Moretti, Roberto Maggi, Monica Marzagalli and Patrizia Limonta


DOI: 10.2174/1574892809666140520113953




MicroRNA Therapeutics: The Emerging Anticancer Strategies

, 9(3): 286 - 296

Chakresh K. Jain, Aman Gupta, Nidhi Dogra, Vipul S. Kumar, Gulshan Wadhwa and Sanjeev K. Sharma


DOI: 10.2174/1574892809666140307101519




Combination of Phytochemicals as Adjuvants for Cancer Therapy

, 9(3): 297 - 302

John W.S. Ho and Matt W.M. Cheung


DOI: 10.2174/1574892809666140619154838




Anticancer Hybrids- A Patent Survey

, 9(3): 303 - 339

Kunal Nepali, Sahil Sharma, Dinesh Kumar, Abhishek Budhiraja and Kanaya L. Dhar


DOI: 10.2174/1574892809666140520150459




Could Resveratrol be a Useful Drug for the Treatment of Malignant Hemopathies?

, 9(3): 340 - 353

Romeo G. Mihaila


DOI: 10.2174/1574892809666140327161242




Novel Patents and Cancer Therapies for Transforming Growth Factor- Beta and Urokinase Type Plasminogen Activator: Potential Use of Their Interplay in Tumorigenesis

, 9(3): 354 - 371

Jelena Krstic, Irina Maslovaric and Juan F. Santibanez


DOI: 10.2174/1574892809666140512145535




Lung Cancer Chemotherapy, New Treatment and Related Patents

, 9(3): 372 - 381

Attapon Cheepsattayakorn and Ruangrong Cheepsattayakorn


DOI: 10.2174/1574892809666140520120806




Next Generation Tyrosine Kinase Inhibitor (TKI): Afatinib

, 9(3): 382 - 393

Suresh Kumar and Ritesh Agrawal


DOI: 10.2174/1574892809666140520114928




Patent Selections:

, 9(3): 394 - 397


DOI: 10.2174/157489280903140723105508




Acknowledgement to Contributors

, 9(3): 398


DOI: 10.2174/157489280903140723105638




Acknowledgement to Reviewers

, 9(3): 399 - 400


DOI: 10.2174/157489280903140723105729




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science